Malásia - inglês - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

ranbaxy (malaysia) sdn. bhd. - risperidone -

Itália - italiano - Ministero della Salute

lohmann & rauscher srl -

Itália - italiano - Ministero della Salute

lohmann & rauscher srl -

União Europeia - dinamarquês - EMA (European Medicines Agency)

cheplapharm arzneimittel gmbh - verteporfin - myopia, degenerative; macular degeneration - oftalmologiske - visudyne er indiceret til behandling af:voksne med exudative (våd) aldersrelateret macula degeneration (amd) med overvejende klassisk subfoveal choroidal neovascularisation (cnv), eller voksne med subfoveal choroidal neovascularisation sekundær til patologisk nærsynethed.

Austrália - inglês - APVMA (Australian Pesticides and Veterinary Medicines Authority)

norbrook laboratories australia pty limited - carprofen - oral tablet - carprofen anti-inflammatory-nonsteroidal active 50.0 mg/tb - musculoskeletal system - dog | bitch | castrate | puppy - analgesic | anti-inflammatory agent | inflammatory joint disease | antipyretic | bone soreness | bruising | bursitis | colic | inflammatory rheumatic arthrit | joint disease | ligament sprains | muscle relaxant | muscle soreness | non-infectious joint disease | osteoarthritis | platelet activity | rheumatism | sedative | spasmolytic | sprains | strains | tendon sprains | traumatic swelling

Austrália - inglês - APVMA (Australian Pesticides and Veterinary Medicines Authority)

norbrook laboratories australia pty limited - carprofen - oral tablet - carprofen anti-inflammatory-nonsteroidal active 100.0 mg/tb - musculoskeletal system - dog | bitch | castrate | puppy - anti-inflammatory agent | antipyretic | bone soreness | bruising | bursitis | inflammatory rheumatic arthrit | joint disease | ligament sprains | muscle soreness | osteoarthritis | platelet activity | rheumatism | sprains | strains | tendon sprains | traumatic swelling

União Europeia - dinamarquês - EMA (European Medicines Agency)

bayer ag - aflibercept - wet macular degeneration; macular edema; diabetes complications - oftalmologiske - eylea er indiceret til voksne til behandling af:neovaskulær (våd) aldersrelateret macula degeneration (amd);synsnedsættelse på grund af macula ødem sekundær til retinal veneokklusion (filial rvo eller central rvo);synsnedsættelse på grund af diabetisk macula ødem (dme);synsnedsættelse på grund af nærsynet choroidal neovascularisation (nærsynet cnv).

União Europeia - dinamarquês - EMA (European Medicines Agency)

viatris limited - aflibercept - macular edema; retinal vein occlusion; diabetic retinopathy; myopia, degenerative; diabetes complications - oftalmologiske - yesafili is indicated for adults for the treatment ofneovascular (wet) age-related macular degeneration (amd) (see section 5. 1),visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo) (see section 5. 1),visual impairment due to diabetic macular oedema (dme) (see section 5. 1),visual impairment due to myopic choroidal neovascularisation (myopic cnv) (see section 5.

União Europeia - dinamarquês - EMA (European Medicines Agency)

samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - oftalmologiske - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

União Europeia - dinamarquês - EMA (European Medicines Agency)

stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologiske - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).